Abiomed sued again; Hospira a rumored takeover candidate;

 @FierceMedDev: Exosome draws $5M in financing for molecular Dx work. Item | Follow @FierceMedDev

 @MarkHFierce: House Majority Leader Eric Cantor has revived the device tax repeal push, as part of Republicans' new platform. Story | Follow @MarkHFierce

 @DamianFierce: Allergan is looking to sell off its Lap-Band business as revenues continue to plummet. News | Follow @DamianFierce

> The lawsuits are growing against Abiomed ($ABMD), accusing the company and its executives of concealing alleged improper marketing of its Impella 2.5 heart pump, and artificially inflating its stock price as a result. Story

> Hospira ($HSP), a maker of infusion pumps and generic drugs, may be a takeover candidate. Story

> EClinicalWorks is devoting $25 million to launch a new mobile health business unit that will focus on engaging patients in order to boost quality and lower costs. Story

> Smiths Medical won FDA clearance for its CADD-Solis VIP ambulatory infusions system equipped with CADD-Solis medication safety software. Release

> Arizona's bioscience sector--which is dominated, in part, by medical device jobs--is growing at four times the national rate. Story

> Scientists are testing specialized glasses based on a new color vision theory to help patients with red-green color blindness. Story

> Guided Therapeutics snatched up global rights from Konica Minolta to develop a non-invasive esophageal cancer detection device based on its own biophotonic technology platform. Release

Biotech News

 @FierceBiotech: Pfizer partner Protalix soars on sale speculation. Report | Follow @FierceBiotech

@JohnCFierce: So Elan has $3.25B to play with? Will they blow it? Analysis | Follow @JohnCFierce

@RyanMFierce: No surprise here. HISUN doesn't want exclusive license to Celsion's ThermoDox for the China market. Release | Follow @RyanMFierce

> Catabasis raises $9M for PhII-ready drug development program. News

> Ipsen, insolvent biotech partner find buyer for troubled hemophilia drug. Report

Pharma News

@FiercePharma: GSK to hack jobs in Europe where austerity has taken toll. Report | Follow @FiercePharma

@EricPFierce: With sale of Tysabri rights to Biogen Idec, Elan is now flush with cash and looking for something to buy. News | Follow @EricPFierce

@AlisonBFierce: Merck and GlaxoSmithKline will work with the GAVI Alliance to provide low-cost HPV vaccines to developing countries. Article | Follow @AlisonBFierce

> Merck loses 'bellwether' Fosamax case. Article

> Is Hospira primed for a takeover? News

Drug Delivery News

> Cloaked nanoparticles look like blood cells, carry drugs. Story

> FDA to review BTG's varicose vein foam injection. News

> Rockwell shows iron delivery drug for dialysis improves treatment. Article

> Langer's Kala scores Cystic Fibrosis Foundation grant. Report

Biomarkers News

> Brain biomarker may help open door to personalized depression drugs. Report

> FDA will make use of GVK biomarker database. Item

> Biomarker could be key to MS Dx and targeted treatment. Article

> Molecules that could predict cancer growth detected. News

> Researcher names protein as plausible autism biomarker. Story

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.